Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHMI-trans sporozoite challenge study of piperaquine protocols for malaria transmission assessment
2016-001379-66Phase 2Terminated
- Sponsor
- Radboud University Medical Center
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of piperaquine in malaria (4 arms), sponsored by Radboud University Medical Center. Primary endpoint: Frequency and magnitude of adverse events. Started May 2016; status: terminated.
02
Drugs
piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on 2016-001379-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001379-66.